Sign In

Ellie Gurary

Principal Biostatistician at CRISPR Therapeutics

Professional Background

Ellie Stukalin is an accomplished biostatistician with a strong educational foundation and extensive professional experience in the field of statistical analysis, particularly within the biopharmaceutical industry. Currently serving as the Principal Biostatistician at CRISPR Therapeutics, Ellie brings a wealth of knowledge and expertise to her role. She has a proven track record of influencing drug development strategies and contributing to the advancement of innovative therapies aimed at improving patient outcomes. Her broad understanding of biostatistics has established her as a key player in the evolving landscape of genetic research and treatment.

Before her current position at CRISPR Therapeutics, Ellie honed her skills at Merck, where she worked as a Senior Scientist in the Biostatistics department. In this role, she was responsible for developing and implementing statistical methodologies to support clinical trials and regulatory submissions. Her keen analytical skills and attention to detail have significantly contributed to the success of numerous projects during her time there.

Ellie's journey in biostatistics began with a strong academic focus, which set the stage for her future career. She served as a Research Assistant at the Boston University Statistical Consulting Unit, where she collaborated with various researchers to apply statistical techniques and inference to their study designs. This initial experience laid the groundwork for her robust understanding of the application of statistics across various domains.

Education and Achievements

Ellie Stukalin’s educational credentials are impressive and demonstrate her commitment to excellence in the field of statistics. She earned her Master's in Statistical Practice from Carnegie Mellon University, where she was able to deepen her knowledge in applied statistics. Her doctoral studies culminated in a Ph.D. in Biostatistics from Boston University, equipping her with advanced statistical and analytical capabilities that are essential for cutting-edge research.

Her Bachelor of Science in Statistics from Carnegie Mellon University provided her with a solid foundation in the principles of statistics, setting the tone for her future studies and professional development. Throughout her educational journey, Ellie demonstrated a passion for learning and a desire to utilize her skills to make a meaningful impact in healthcare.

Additionally, Ellie has played an important role in education as a Teaching Assistant at both Boston University and Carnegie Mellon University, sharing her knowledge of statistics with students and helping to inspire the next generation of statisticians.

Professional Experience

Over the years, Ellie has accumulated diverse experience, beginning with her role as a Statistician at National Analysts Worldwide, where she engaged in statistical analysis for various projects, gaining valuable insight into the industry. Additionally, she completed a Statistics and Law Internship at Carnegie Mellon University, blending her interest in statistical analysis with legal considerations, showcasing her versatility in different contexts. Her experience as a Research Trainee at Brigham and Women's Hospital further solidified her understanding of the healthcare sector and the importance of rigorous statistical methods in clinical research.

Ellie’s multifaceted career reflects her commitment to advancing the field of biostatistics. She is known for her collaborative spirit, technical proficiency, and the ability to communicate complex statistical concepts in an accessible way.

Achievements

Notably, Ellie Stukalin is recognized for her contributions to numerous successful clinical trials and studies that have led to the development of new treatments in the biotech industry. Her work at CRISPR Therapeutics has been pivotal in the area of gene editing, supporting transformative initiatives that push the boundaries of modern medicine.

She has also authored and co-authored numerous publications in esteemed statistical and medical journals, further disseminating knowledge and establishing her as a thought leader in biostatistical methodologies. Ellie's research has not only advanced her professional standing but also benefited public health strategies by enhancing the statistical frameworks used in clinical research.

Ellie’s dedication to her field and her robust professional history underscore her status as a respected biostatistician. Her journey is characterized by continuous learning, collaboration, and a passion for leveraging statistics to improve healthcare outcomes. With her strong academic background, practical experience, and commitment to excellence, Ellie Stukalin exemplifies professionalism in the realm of biostatistics.

Related Questions

What motivated Ellie Stukalin to pursue a PhD in Biostatistics?
How did Ellie Stukalin’s education at Carnegie Mellon University shape her career in biostatistics?
What significant contributions has Ellie Stukalin made during her tenure at CRISPR Therapeutics?
In what ways has Ellie Stukalin's experience at Merck influenced her approach to biostatistics?
How does Ellie Stukalin integrate her statistical expertise into the projects she works on at CRISPR Therapeutics?
Ellie Gurary
Add to my network

Location

Boston, Massachusetts, United States